RAIADROGASIL (RADL3) Main Indicators
Company Basic Data| Company | RAIADROGASIL |
| Corporate Name | RAIA DROGASIL S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comércio de produtos farmacêuticos. perfumaria e afins. |
| Share | RADL3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 19.01 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 126.29 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | GPTW, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 04/02/2025 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
|---|
| Price/Earnings | 27.22 |
| Price/SBV | 5.08 |
| Price/Net Sales | 0.84 |
| Price/CFO | 11.78 |
| Price/FCF | 21.89 |
| Price/Total Assets | 1.47 |
| Price/EBIT | 13.89 |
| Price/Working Capital | 9.31 |
| Price/NCAV | -2.67 |
| EV/EBIT | 15.06 |
| EV/EBITDA | 8.53 |
| EV/Net Sales | 0.91 |
| EV/CFO | 12.78 |
| EV/FCF | 23.75 |
| EV/Total Assets | 1.60 |
| Company Market Cap | R$ 32.66 B |
| Enterprise Value | R$ 35.43 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 19.01 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 1.78% |
Summary Income Statement Last 12 Months | |
|---|
| Net Revenue | R$ 38.87 B |
| Gross Result | R$ 11.56 B |
| EBIT | R$ 2.35 B |
| Depreciation and Amortization | - R$ 1.80 B |
| EBITDA | R$ 4.15 B |
| Net Profit | R$ 1.20 B |
| Net Profit/Share | R$ 0.70 |
Summary Income Statement Last Quarter | |
|---|
| Net Revenue | R$ 10.09 B |
| Gross Result | R$ 2.99 B |
| EBIT | R$ 491.49 M |
| Depreciation and Amortization | - R$ 414.66 M |
| EBITDA | R$ 906.14 M |
| Net Profit | R$ 350.40 M |
| Profit/Share | R$ 0.20 |
Stock Price and Stock Volume Behavior| Lowest Price 52 weeks | R$ 17.38 |
| Highest Price 52 weeks | R$ 29.83 |
| Variation 2025 | -12.64% |
| Variation 1 year | -28.12% |
| Variation 2 years(total) | -17.12% |
| Variation 2 years(yearly) | -8.94% |
| Variation 3 years(total) | -15.12% |
| Variation 3 years(yearly) | -5.31% |
| Variation 4 years(total) | -15.63% |
| Variation 4 years(yearly) | -4.16% |
| Variation 5 years(total) | 0.46% |
| Variation 5 years(yearly) | 0.09% |
| Average Daily Volume (3 months) | R$ 201.53 M |
| Updated 04/02/2025 |
Returns, Margins, and Other Measures | |
|---|
| Return on Initial Tangible Capital | 15.09% |
| Return on Initial Invested Capital | 17.90% |
| Pre-Tax Return on Initial Tangible Capital | 22.86% |
| Pre-Tax Return on Initial Invested Capital | 27.12% |
| Return on Initial Shareholder´s Equity | 20.15% |
| Return on Initial Asset | 5.97% |
| Gross Margin | 29.73% |
| Net Margin | 3.09% |
| EBIT Margin | 6.05% |
| EBITDA Margin | 10.69% |
| Initial Asset Turnover | 1.93 |
| Financial Leverage | 3.45 |
| Liabilities/Net Worth | 2.45 |
| Net Debt/EBITDA | 0.67 |
Summary Balance Sheet | |
|---|
| Cash and Cash Equivalents | R$ 528.00 M |
| Total Assets | R$ 22.16 B |
| Short-Term Debt | R$ 637.11 M |
| Long-Term Debt | R$ 2.66 B |
| Gross Debt | R$ 3.29 B |
| Net Debt | R$ 2.77 B |
| Shareholder´s Equity | R$ 6.43 B |
| Share Book Value | R$ 3.74 |
| Common Shares | 1,718,007,200 |
| Preferred Shares | 0 |
| Total | 1,718,007,200 |
| Common Shares in Treasury | 6,012,572 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 6,012,572 |
| Common Shares (Except Treasury) | 1,711,994,628 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,711,994,628 |
Summary Cash Flow Statement Last 12 Months | |
|---|
| Operating Cash Flow | R$ 2.77 B |
| Cash Flow from Investments | - R$ 1.41 B |
| Financing Cash Flow | - R$ 1.24 B |
| Increase (Reduction) in Cash and Equivalents | R$ 115.68 M |
Summary Cash Flow Statement Last Quarter | |
|---|
| Operating Cash Flow | R$ 1.09 B |
| Cash Flow from Investments | - R$ 564.90 M |
| Financing Cash Flow | - R$ 404.06 M |
| Increase (Reduction) in Cash and Equivalents | R$ 117.49 M |
Experimental CAPEX and Free Cash Flow Calculation | |
|---|
| CAPEX 3 months | - R$ 431.37 M |
| Free Cash Flow 3 months | R$ 655.07 M |
| CAPEX 12 months | - R$ 1.28 B |
| Free Cash Flow 12 months | R$ 1.49 B |